Scientific Reviews · Nov 17, 2026
The dark side of obesity: the role of sleep deprivation and melatonin in appetite regulation and metabolic dysfunction
By Parol W, Pacak M, Krętowski AJ et al.
Background: Obesity is a chronic metabolic disease with a multifactorial etiology. Beyond excessive caloric intake and low physical activity, growing evidence indicates that insufficient sleep, circadian disruption, and altered melatonin signaling contribute to appetite dysregulation and adverse metabolic outcomes. Objective: The aim of this narrative review was to summarize current evidence on the effects of sleep deprivation and melatonin on appetite regulation, body weight, and energy metabolism, with particular emphasis on neuroendocrine pathways, reward-related eating behavior, circadian misalignment, and the role of melatonin receptors MT1 and MT2. Methods: A narrative review of the literature was conducted using a primary PubMed search covering January 2011–June 2026, supplemented by selected seminal mechanistic studies published before 2011. Experimental and observational studies, systematic reviews, meta-analyses, and mechanistic papers related to sleep restriction, circadian biology, melatonin, and metabolic regulation were considered; the search strategy and eligibility criteria are described in the Materials and Methods section. Results: Sleep deprivation is associated with greater hunger and a higher preference for energy-dense foods, whereas its effects on circulating leptin and ghrelin are inconsistent across studies. It also affects hypothalamic signaling and reward-related eating behavior through alterations in prefrontal cortex activity and dopaminergic pathways. Circadian misalignment contributes to metabolic dysfunction and may increase obesity risk. Melatonin influences both chronobiological and metabolic regulation, while MT1 and MT2 receptors—including the MTNR1B genetic axis—further support the link between circadian biology and metabolic risk. Conclusions: Adequate sleep and proper circadian alignment should be recognized as clinically relevant, modifiable factors in obesity prevention and metabolic health. Melatonin serves as a key integrative signal between circadian timing and metabolism, although its effects remain highly context-dependent. The contribution of this review is to move beyond the classical leptin–ghrelin paradigm and to integrate, within a single mechanistic framework, three strands of evidence that are usually considered in isolation: the neuroendocrine and hedonic reward pathways through which sleep loss shifts appetite toward positive energy balance; the desynchronization between the central clock and peripheral tissue clocks; and the MTNR1B/MT1–MT2 receptor genetics that link circadian biology to individual metabolic risk. At a time when short sleep, shift work, and nighttime light exposure are increasingly prevalent, this synthesis is particularly timely. By relating these mechanisms to modifiable targets—sleep duration and regularity, meal timing, and light hygiene—and identifying genotype-informed chronotherapy as a potential future research direction, the review offers clinicians, researchers, and public-health audiences a mechanistically grounded basis for considering sleep and circadian principles in obesity management and metabolic risk assessment.